HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GnRHa for adhesion formation after uterine serosal injury in an euestrogenic milieu.

AbstractOBJECTIVE:
To assess whether the adhesion-preventing effect of gonadotropin-releasing hormone agonist (GnRHa) is through hypoestrogenism.
STUDY DESIGN:
Four groups of previously ovariectomized rats received various combinations of depot leuprolide acetate injection (3.75 mg/kg/mo) subcutaneously, conjugated equine estrogens (50 micrograms/kg/d) orally and phosphate-buffered saline injection subcutaneously, yielding group 1, saline only; group 2, saline and conjugated equine estrogens; group 3, depot leuprolide acetate only; and group 4, depot leuprolide acetate and conjugated equine estrogens. Surgical adhesions were induced by monopolar cautery on the right uterine horn through laparotomy and were then scored on day 21 after surgery.
RESULTS:
Adhesion scores for rats that received conjugated equine estrogens and saline were significantly higher than scores of those given conjugated equine estrogens and depot leuprolide acetate, depot leuprolide acetate only and saline only (P = .019, .026 and .027, respectively). However, there was no significant difference in the adhesion scores for these three groups.
CONCLUSION:
Hypoestrogenism results in the development of fewer peritoneal adhesions postoperatively. Our findings also indicated that other mechanisms, in addition to those inducing hypoestrogenism, are at work in the adhesion-preventing effects of GnRHa therapy.
AuthorsM H Ergeneli, E Kuscu, H B Zeyneloglu, A Haberal, M Erdogan
JournalThe Journal of reproductive medicine (J Reprod Med) Vol. 45 Issue 1 Pg. 35-8 (Jan 2000) ISSN: 0024-7758 [Print] United States
PMID10664945 (Publication Type: Journal Article)
Chemical References
  • Delayed-Action Preparations
  • Estrogens, Conjugated (USP)
  • Leuprolide
Topics
  • Animals
  • Delayed-Action Preparations
  • Estrogens, Conjugated (USP) (administration & dosage, pharmacology)
  • Female
  • Horses
  • Leuprolide (administration & dosage, therapeutic use)
  • Ovariectomy
  • Postoperative Complications (prevention & control)
  • Rats
  • Rats, Wistar
  • Tissue Adhesions (prevention & control)
  • Uterine Diseases (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: